A Prescription Trend Analysis of Methylphenidate: Relation to Study Reports on Efficacy

Maruschka N Sluiter*, Ymkje Anna de Vries, Lotte G. Koning, Eelko Hak, Jens H. J. Bos, Catharina C. M. Schuiling-Veninga, Laura Batstra, Jeannette M. Doornenbal, Peter de Jonge

*Bijbehorende auteur voor dit werk

OnderzoeksoutputAcademicpeer review

1 Citaat (Scopus)
81 Downloads (Pure)


Use of methylphenidate in children has increased substantially, despite conflicting evidence regarding efficacy. In this study, prescription data were analyzed in relation to the publication of new evidence regarding efficacy. Incidence rates and prescribed doses of methylphenidate increased, with a decline during the last few years. Duration of use is still increasing. In half of the cases, starting dosages are higher than recommended in guidelines. There was little evidence that publication of new evidence directly influenced the use of methylphenidate. Recent and critical study findings should receive more attention to contribute to the development and use of treatment guidelines for ADHD and evidence-based methylphenidate use.

Originele taal-2English
Pagina's (van-tot)291–299
Aantal pagina's9
TijdschriftAdministration and Policy in Mental Health and Mental Health Services Research
Nummer van het tijdschrift2
Vroegere onlinedatum16-okt-2019
StatusPublished - mrt-2020

Citeer dit